Prime Medicine's market value is the price at which a share of Prime Medicine trades on a public exchange. It measures the collective expectations of Prime Medicine Common investors about its performance. Prime Medicine is trading at 4.15 as of the 30th of January 2026, a 2.98 percent up since the beginning of the trading day. The etf's lowest day price was 4.03. With this module, you can estimate the performance of a buy and hold strategy of Prime Medicine Common and determine expected loss or profit from investing in Prime Medicine over a given investment horizon. Check out Prime Medicine Correlation, Prime Medicine Volatility and Prime Medicine Performance module to complement your research on Prime Medicine.
Symbol
Prime
Prime Medicine Common's market price often diverges from its book value, the accounting figure shown on Prime's balance sheet. Smart investors calculate Prime Medicine's intrinsic value—its true economic worth—which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Prime Medicine's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Prime Medicine's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Prime Medicine should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Prime Medicine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Prime Medicine 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Prime Medicine's etf what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Prime Medicine.
0.00
11/01/2025
No Change 0.00
0.0
In 3 months and 1 day
01/30/2026
0.00
If you would invest 0.00 in Prime Medicine on November 1, 2025 and sell it all today you would earn a total of 0.00 from holding Prime Medicine Common or generate 0.0% return on investment in Prime Medicine over 90 days. Prime Medicine is related to or competes with Maravai Lifesciences, Kura Oncology, Bicara Therapeutics, Vir Biotechnology, Replimune, Septerna Common, and Tyra Biosciences. Prime Medicine, Inc., a biotechnology company, delivers genetic therapies to address diseases by deploying gene editing ... More
Prime Medicine Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Prime Medicine's etf current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Prime Medicine Common upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Prime Medicine's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Prime Medicine's standard deviation. In reality, there are many statistical measures that can use Prime Medicine historical prices to predict the future Prime Medicine's volatility.
Prime Medicine Common maintains Sharpe Ratio (i.e., Efficiency) of close to zero, which implies the entity had a close to zero % return per unit of risk over the last 3 months. Prime Medicine Common exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Prime Medicine's Risk Adjusted Performance of (0.02), variance of 34.67, and Coefficient Of Variation of (2,773) to confirm the risk estimate we provide. The etf holds a Beta of 1.1, which implies a somewhat significant risk relative to the market. Prime Medicine returns are very sensitive to returns on the market. As the market goes up or down, Prime Medicine is expected to follow.
Auto-correlation
0.32
Below average predictability
Prime Medicine Common has below average predictability. Overlapping area represents the amount of predictability between Prime Medicine time series from 1st of November 2025 to 16th of December 2025 and 16th of December 2025 to 30th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Prime Medicine Common price movement. The serial correlation of 0.32 indicates that nearly 32.0% of current Prime Medicine price fluctuation can be explain by its past prices.
Correlation Coefficient
0.32
Spearman Rank Test
-0.11
Residual Average
0.0
Price Variance
0.1
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Prime Medicine financial ratios help investors to determine whether Prime Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Prime with respect to the benefits of owning Prime Medicine security.